Determination of Microbiological Factors Associated With Poor Response to Neoadjuvant Treatment in Rectal Cancers

Abroad (travel likely)Recruiting

Conditions

Rectal Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Institut régional du Cancer de Montpellier, Montpellier, Hérault, France
Contact: Study coordinator (Philippe ROUANET, MD) · Philippe.Rouanet@icm.unicancer.fr · 4 67 61 45 86
CHU Clermont-Ferrand, Clermont-Ferrand, Puy De Dôme, France
Contact: Study coordinator (Johan Gagnières, MD) · jgagniere@chu-clermontferrand.fr

Study leads

Philippe ROUANET, MD
Study Chair
Institut régional du cancer de Montpellier

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Interest of PET-MRI in the Evaluation of the Response After Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma

Rectal Cancer

Abroad (travel likely)Recruiting

Strasbourg, France

SIS-Reinforced vs. Conventional Anastomosis for Mid-to-Low Rectal Cancer: A Multicenter RCT on Anastomotic Leak

Rectal Cancer

Abroad (travel likely)RecruitingPHASE4

Beijing, China

A Study of a Urine Test to Detect Colorectal Cancer

Colorectal Cancer · Precancerous Polyp · Rectal Bleeding

Abroad (travel likely)Recruiting

New York, United States · Accra, Ghana

Different-Dose SCRT Plus CAPOX, PD-1 Blockade and IL-2 in LARC

Rectal Cancer · Radiotherapy

Abroad (travel likely)RecruitingPHASE2

Nanjing, China